MAGE, NCT00704041: Four Doses of Vaccine for Patients With Squamous Cell Carcinoma of the Head and Neck |
|
|
| Recruiting | 1 | 48 | US | MAGE-A3 HPV-16 vaccine, MAGE-A3/HPV 16 Trojan Peptides 0001 and 0002 | University of Maryland, National Institutes of Health (NIH) | Squamous Cell Carcinoma, Head and Neck Cancer | 06/10 | 06/12 | | |